JP2017501967A - 新規なペプチド組成物 - Google Patents

新規なペプチド組成物 Download PDF

Info

Publication number
JP2017501967A
JP2017501967A JP2016521985A JP2016521985A JP2017501967A JP 2017501967 A JP2017501967 A JP 2017501967A JP 2016521985 A JP2016521985 A JP 2016521985A JP 2016521985 A JP2016521985 A JP 2016521985A JP 2017501967 A JP2017501967 A JP 2017501967A
Authority
JP
Japan
Prior art keywords
peptide
body weight
xaa
amino acid
ala
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016521985A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017501967A5 (enExample
Inventor
リチャード フランクリン，
リチャード フランクリン，
Original Assignee
タリックス ファーマシューティカルズ リミテッド
タリックス ファーマシューティカルズ リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by タリックス ファーマシューティカルズ リミテッド, タリックス ファーマシューティカルズ リミテッド filed Critical タリックス ファーマシューティカルズ リミテッド
Publication of JP2017501967A publication Critical patent/JP2017501967A/ja
Publication of JP2017501967A5 publication Critical patent/JP2017501967A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
JP2016521985A 2013-10-11 2014-10-01 新規なペプチド組成物 Pending JP2017501967A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361890056P 2013-10-11 2013-10-11
US61/890,056 2013-10-11
US201461940095P 2014-02-14 2014-02-14
US61/940,095 2014-02-14
PCT/US2014/058646 WO2015054006A2 (en) 2013-10-11 2014-10-01 Novel peptide compositions

Publications (2)

Publication Number Publication Date
JP2017501967A true JP2017501967A (ja) 2017-01-19
JP2017501967A5 JP2017501967A5 (enExample) 2017-11-09

Family

ID=52813728

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016521985A Pending JP2017501967A (ja) 2013-10-11 2014-10-01 新規なペプチド組成物

Country Status (13)

Country Link
EP (1) EP3054967A4 (enExample)
JP (1) JP2017501967A (enExample)
KR (1) KR20160065969A (enExample)
CN (1) CN105828831A (enExample)
AU (1) AU2014332346B2 (enExample)
BR (1) BR112016007816A2 (enExample)
CA (1) CA2926641A1 (enExample)
CL (1) CL2016000836A1 (enExample)
IL (1) IL244956B (enExample)
MX (1) MX2016004660A (enExample)
RU (1) RU2016112931A (enExample)
SG (1) SG11201602661PA (enExample)
WO (1) WO2015054006A2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6863362B2 (ja) * 2016-03-03 2021-04-21 不二製油株式会社 神経栄養因子の脳内分泌促進するための食品添加用組成物
EA201991699A1 (ru) * 2017-02-16 2020-01-21 Кареджен Ко., Лтд. Конъюгат салициловой кислоты и пептида

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005511015A (ja) * 2001-08-24 2005-04-28 ニューロンズ・リミテッド 神経再生ペプチドおよび脳損傷治療におけるその使用方法
WO2007011595A2 (en) * 2005-07-15 2007-01-25 Neuren Pharmaceuticals Limited Neural regeneration peptides and antioxidants protect neurons from degeneration
JP2007511210A (ja) * 2003-10-31 2007-05-10 ニューレン ファーマシューティカルズ リミテッド 神経再生ペプチド及び脳損傷治療におけるそれらの使用方法
WO2013119870A1 (en) * 2012-02-10 2013-08-15 Tarix Pharmaceuticals Ltd. Compositions and methods for treatment of peripheral vascular disease

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4244946A (en) 1979-06-11 1981-01-13 The Salk Institute For Biological Studies Water-soluble peptides affecting gonadal function
US4305872A (en) 1979-10-19 1981-12-15 Kenneth Wingrove Polypeptide derivatives
US4316891A (en) 1980-06-14 1982-02-23 The Salk Institute For Biological Studies Extended N-terminal somatostatin
DE69738326T2 (de) 1996-07-12 2008-07-03 Mcgill University, Montreal Verbindungen und verfahren zur regulierung der zellanlagerung
WO2001053331A2 (en) 2000-01-24 2001-07-26 Adherex Technologies, Inc. Peptidomimetic modulators of cell adhesion
US7563862B2 (en) 2001-08-24 2009-07-21 Neuren Pharmaceuticals Limited Neural regeneration peptides and methods for their use in treatment of brain damage
AU2003293807A1 (en) * 2002-12-24 2004-07-22 Algonomics N.V. Mhc class i restricted t-cell stimulating peptides from hepatitis b virus
WO2012006598A2 (en) * 2010-07-09 2012-01-12 Dana-Farber Cancer Institute, Inc. Stabilized insulinotropic peptides and methods of use

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005511015A (ja) * 2001-08-24 2005-04-28 ニューロンズ・リミテッド 神経再生ペプチドおよび脳損傷治療におけるその使用方法
JP2007511210A (ja) * 2003-10-31 2007-05-10 ニューレン ファーマシューティカルズ リミテッド 神経再生ペプチド及び脳損傷治療におけるそれらの使用方法
WO2007011595A2 (en) * 2005-07-15 2007-01-25 Neuren Pharmaceuticals Limited Neural regeneration peptides and antioxidants protect neurons from degeneration
WO2013119870A1 (en) * 2012-02-10 2013-08-15 Tarix Pharmaceuticals Ltd. Compositions and methods for treatment of peripheral vascular disease

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE DDBJ/EMBL/GENBANK [ONLINE], ACCESSIN NO. EIK93378.1, <HTTPS://WWW.NCBI.NLM.NIH.GOV/PROTEIN/, JPN7018002696, ISSN: 0004213236 *

Also Published As

Publication number Publication date
CN105828831A (zh) 2016-08-03
IL244956B (en) 2019-10-31
SG11201602661PA (en) 2016-05-30
KR20160065969A (ko) 2016-06-09
EP3054967A4 (en) 2017-04-19
BR112016007816A2 (pt) 2017-12-05
WO2015054006A2 (en) 2015-04-16
AU2014332346B2 (en) 2019-01-24
CA2926641A1 (en) 2015-04-16
MX2016004660A (es) 2016-11-14
EP3054967A2 (en) 2016-08-17
WO2015054006A3 (en) 2015-06-04
AU2014332346A1 (en) 2016-05-05
IL244956A0 (en) 2016-05-31
RU2016112931A (ru) 2017-11-16
CL2016000836A1 (es) 2016-09-16
RU2016112931A3 (enExample) 2018-06-20

Similar Documents

Publication Publication Date Title
AU2018205186B2 (en) Angiotensin in treating brain conditions
US20180050079A1 (en) Angiotensin peptides in treating marfan syndrome and related disorders
JP2018530590A (ja) 表皮水疱症の処置のための方法及び組成物
US20180221433A1 (en) Angiotensins in muscular dystrophy
US9333233B2 (en) Methods and compositions for the delayed treatment of stroke
JP2017501967A (ja) 新規なペプチド組成物
US9133241B2 (en) Peptide compositions
WO2015057403A2 (en) Compositions and methods for treatment of inflammatory bowel disease

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170927

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170927

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20180725

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180808

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20181031

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190201

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190704

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20200214